EU launches legal action against vaccine-maker AstraZeneca


PTI, Apr 26, 2021, 7:23 PM IST

Brussels: The European Union’s executive branch said Monday that it has launched legal action against COVID-19 vaccine-maker AstraZeneca for failing to respect the terms of its contract with the 27-country bloc.

The AstraZeneca vaccine has been central to Europe’s immunisation campaign, and a linchpin in the global strategy to get vaccines to poorer countries. But the slow pace of deliveries has frustrated the Europeans and has been blamed in part for holding up the EU’s vaccine rollout.

European Commission spokesman Stefan De Keersmaecker said that Brussels launched the legal action against AstraZeneca last Friday “on the basis of breaches of the advance purchase agreement.”

He said the reason for the legal action was that “some terms of the contract have not been respected” and that “the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses.”

AstraZeneca’s contract with the EU foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million.

But only 30 million doses were delivered in the first quarter of 2021, and the company says it can provide 70 million in the second quarter, rather than the 180 million it had promised.

AstraZeneca has previously said that its contract with the EU contained vaccine delivery targets, not firm commitments and that the company was unable to meet them because of early problems with rapidly expanding its production capacity.

Last month, the Commission launched a dispute resolution mechanism aimed at amicably addressing its differences with the company.

Brussels said its focus is to ensure timely deliveries of vaccines.

It since said that its option for extra AstraZeneca doses will not be taken up.

Last week, Commission President Ursula von der Leyen announced that a new vaccine contract is set to be concluded with BioNTech-Pfizer for 1.8 billion doses for the 2021-23 period.

She said the deal will ensure doses for booster shots, vaccines adapted to new variants, and, potentially, vaccines for children and teenagers.

Von der Leyen said the EU, home to around 450 million people, has “already passed 123 million vaccinations” and is on track to have vaccinated 70% of all adults by July. Previously the target had been September.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Indian embassy urges caution for non-essential travel to UAE amid historic flooding

PM Modi accuses previous governments of deceiving SC, ST, OBCs in the guise of social justice at Amroha rally

BJP too echoes ‘JP-JP’ chorus in Udupi-Chikkamagalur: Cong leader Niketraj Maurya

Sanjay Singh warns of conspiracy against Kejriwal, fears for his safety in jail

Remarks on Allopathy: SC asks Ramdev to implead complainants in his plea for stay of criminal probes

Women voters outnumber men in all 5 Assam LS seats where voting is underway

Bangalore never had woman MP & Cong’s Sowmya Reddy wants to make history

Related Articles More

Biden administration official backs reform of UN in response to Musk’s comments on permanent UNSC seat for India

Russia initiates withdrawal of peacekeeping forces from Karabakh as Azerbaijan takes full control of the region

Unprecedented rainfall in Dubai: Social media flooded with visuals of submerged airport & streets

Israel’s Defense Innovations: From Iron Dome to Arrow 3

Heavy rains set off flash floods killing 33 people in Afghanistan

MUST WATCH

Grafting Jack Anil

Heat Illness

Dwarakish death at 81

H. D. Deve Gowda

Aura Cake shop in udupi


Latest Additions

Why crime rate against Dalits increasing in MP: Cong jabs PM Modi

Indian embassy urges caution for non-essential travel to UAE amid historic flooding

Kullur: Pedestrian killed in road accident

PM Modi accuses previous governments of deceiving SC, ST, OBCs in the guise of social justice at Amroha rally

Nadda says Rahul Gandhi believes in dynastic rule

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.